D14. Evaluation of the Relative Safety of Oncoplastic Reduction Compared to Traditional Reduction

• Elijah Bingham, BS,
• Shamit Prabhu, MD,
• Nirbhay S. Jain, MD,
• Andrew Da Lio, MD,
• Charles Tseng, MD,
• Christopher Crisera, MD,
• Jaco Festekjian, MD,
• Jason Roostaeian, MD,
• Ginger Slack, MD,
• Michael Delong, MD

Affiliations

Elijah Bingham, BS

Division of Plastic and Reconstructive Surgery, University of California Los Angeles, Los Angeles, CA, USA.

Shamit Prabhu, MD

Division of Plastic and Reconstructive Surgery, University of California Los Angeles, Los Angeles, CA, USA.

Nirbhay S. Jain, MD

Division of Plastic and Reconstructive Surgery, University of California Los Angeles, Los Angeles, CA, USA.

Andrew Da Lio, MD

Division of Plastic and Reconstructive Surgery, University of California Los Angeles, Los Angeles, CA, USA.

Charles Tseng, MD

Division of Plastic and Reconstructive Surgery, University of California Los Angeles, Los Angeles, CA, USA.

Christopher Crisera, MD

Division of Plastic and Reconstructive Surgery, University of California Los Angeles, Los Angeles, CA, USA.

Jaco Festekjian, MD

Division of Plastic and Reconstructive Surgery, University of California Los Angeles, Los Angeles, CA, USA.

Jason Roostaeian, MD

Division of Plastic and Reconstructive Surgery, University of California Los Angeles, Los Angeles, CA, USA.

Ginger Slack, MD

Division of Plastic and Reconstructive Surgery, University of California Los Angeles, Los Angeles, CA, USA.

Michael Delong, MD

Division of Plastic and Reconstructive Surgery, University of California Los Angeles, Los Angeles, CA, USA.